Cooper ROA 2010-2022 | COO

Current and historical return on assets (ROA) values for Cooper (COO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Cooper ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2022-04-30 $0.95B $11.78B 8.89%
2022-01-31 $0.94B $11.66B 9.41%
2021-10-31 $2.95B $9.61B 31.71%
2021-07-31 $2.92B $9.61B 34.02%
2021-04-30 $2.36B $9.01B 29.98%
2021-01-31 $2.25B $8.92B 31.11%
2020-10-31 $0.24B $6.74B 3.60%
2020-07-31 $0.28B $6.75B 4.28%
2020-04-30 $0.34B $6.51B 5.39%
2020-01-31 $0.45B $6.55B 7.21%
2019-10-31 $0.47B $6.28B 7.47%
2019-07-31 $0.45B $6.17B 7.20%
2019-04-30 $0.43B $6.20B 6.87%
2019-01-31 $0.37B $6.30B 5.84%
2018-10-31 $0.14B $6.11B 2.24%
2018-07-31 $0.13B $6.26B 2.15%
2018-04-30 $0.13B $6.41B 2.35%
2018-01-31 $0.18B $6.27B 3.39%
2017-10-31 $0.37B $4.86B 7.85%
2017-07-31 $0.35B $4.78B 7.41%
2017-04-30 $0.33B $4.75B 7.14%
2017-01-31 $0.30B $4.66B 6.52%
2016-10-31 $0.27B $4.48B 6.06%
2016-07-31 $0.25B $4.59B 5.54%
2016-04-30 $0.21B $4.60B 4.63%
2016-01-31 $0.19B $4.40B 4.39%
2015-10-31 $0.20B $4.46B 4.63%
2015-07-31 $0.20B $4.42B 4.50%
2015-04-30 $0.24B $4.39B 5.82%
2015-01-31 $0.26B $4.34B 6.73%
2014-10-31 $0.27B $4.46B 7.63%
2014-07-31 $0.30B $3.37B 9.22%
2014-04-30 $0.30B $3.22B 9.52%
2014-01-31 $0.29B $3.12B 9.59%
2013-10-31 $0.30B $3.14B 9.80%
2013-07-31 $0.31B $3.01B 10.47%
2013-04-30 $0.29B $2.97B 9.83%
2013-01-31 $0.27B $2.97B 9.42%
2012-10-31 $0.25B $2.94B 9.01%
2012-07-31 $0.23B $2.88B 8.72%
2012-04-30 $0.21B $2.63B 8.06%
2012-01-31 $0.19B $2.60B 7.30%
2011-10-31 $0.18B $2.63B 6.71%
2011-07-31 $0.17B $2.62B 6.42%
2011-04-30 $0.16B $2.63B 6.34%
2011-01-31 $0.13B $2.57B 5.18%
2010-10-31 $0.11B $2.53B 4.45%
2010-07-31 $0.09B $2.50B 3.73%
2010-04-30 $0.08B $2.51B 2.99%
2010-01-31 $0.10B $2.52B 3.80%
2009-10-31 $0.10B $2.55B 3.95%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.446B $2.923B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $76.093B 22.10
McKesson (MCK) United States $53.389B 15.50
AmerisourceBergen (ABC) United States $31.591B 13.95
West Pharmaceutical Services (WST) United States $25.237B 38.42
Laboratory Of America Holdings (LH) United States $24.116B 10.55
Cardinal Health (CAH) United States $19.062B 13.83
CONMED (CNMD) United States $3.144B 30.99
Invacare (IVC) United States $0.035B 0.00